Recent news

European commission has granted €6 million for Faron’s Traumakine program

20121129.pdf (286.2 kt)

Euroopan unionilta 6 miljoonaa euroa Faronin Traumakineohjelmalle

20121129_fi.pdf (830.1 kt)

Faron was granted the final Young Innovative Company support by Tekes

20121101.pdf (940.8 kt)

New data from the FPCLI001 study presented at the 2012 ATS meeting

20120521.pdf (56.2 kt)
More news...

Faron is a virtual drug company focusing to discovery and development of proprietary new compounds/use for:

  • vasculopathies
  • traumas
  • inflammation
  • metastasis